IMPURITIES AVAILABLE FOR 'Cabazitaxel'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Cabazitaxel. Cabazitaxel is a semisynthetic taxane chemotherapy agent used primarily for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in patients previously treated with docetaxel. It works by binding to tubulin and promoting microtubule stabilization, thereby inhibiting cell division and inducing apoptosis in cancer cells. Cabazitaxel is effective against tumors resistant to other taxanes due to its lower affinity for P-glycoprotein, which reduces drug efflux. It is administered intravenously, typically in combination with prednisone, every three weeks. Common side effects include neutropenia, anemia, diarrhea, fatigue, and peripheral neuropathy. Serious risks include severe myelosuppression, infections, and hypersensitivity reactions, requiring premedication and close monitoring. Dose adjustments may be necessary in patients with hepatic impairment. Buy high quality Cabazitaxel from Omsynth Lifesciences.